Literature DB >> 15700109

Identification and characterisation of soluble epoxide hydrolase in mouse brain by a robust protein biochemical method.

J-H Shin1, E Engidawork, J-M Delabar, G Lubec.   

Abstract

The central nervous system is an important potential target for certain environmental prototoxins, but relatively little is known regarding brain-specific expression of biotransformation enzyme systems. On the other hand, developments in the field of molecular biology and advances in high-throughput screening methods continue to increase the number and amounts of available proteins. We used thus a robust and reliable technique, two-dimensional gel electrophoresis coupled to matrix assisted laser desorption/ionisation mass spectroscopy followed by tandem mass spectrometry and identified for the first time soluble epoxide hydrolase and added other biotransformation enzymes in the hippocampal region of mouse brain. Soluble epoxide hydrolase has an Mr of 61.5 kDa, pI of 5.9, twenty-six matching peptides and sequence coverage of 56% and was unambiguously identified by MS/MS. Since localised biotransformation events in regions of the central nervous system may account for pathologies and/or toxicities initiated by exposure to certain endogenous and/or environmental chemicals, identification of these enzymes would present an opportunity for developing novel therapeutic targets or would have critical toxicologic significance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15700109     DOI: 10.1007/s00726-004-0145-x

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  5 in total

1.  A cytochrome P450-derived epoxygenated metabolite of anandamide is a potent cannabinoid receptor 2-selective agonist.

Authors:  Natasha T Snider; James A Nast; Laura A Tesmer; Paul F Hollenberg
Journal:  Mol Pharmacol       Date:  2009-01-26       Impact factor: 4.436

2.  Soluble epoxide hydrolase: a novel therapeutic target in stroke.

Authors:  Wenri Zhang; Ines P Koerner; Ruediger Noppens; Marjorie Grafe; Hsing-Ju Tsai; Christophe Morisseau; Ayala Luria; Bruce D Hammock; John R Falck; Nabil J Alkayed
Journal:  J Cereb Blood Flow Metab       Date:  2007-04-18       Impact factor: 6.200

3.  Distribution and expression of soluble epoxide hydrolase in human brain.

Authors:  Priyanka Sura; Radhakrishna Sura; Ahmed E Enayetallah; David F Grant
Journal:  J Histochem Cytochem       Date:  2008-03-03       Impact factor: 2.479

Review 4.  Epoxyeicosanoid signaling in CNS function and disease.

Authors:  Jeffrey J Iliff; Jia Jia; Jonathan Nelson; Toru Goyagi; Judy Klaus; Nabil J Alkayed
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-06-21       Impact factor: 3.072

5.  Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer's disease.

Authors:  Yoko Tajima; Masaki Ishikawa; Keiko Maekawa; Mayumi Murayama; Yuya Senoo; Tomoko Nishimaki-Mogami; Hiroki Nakanishi; Kazutaka Ikeda; Makoto Arita; Ryo Taguchi; Alato Okuno; Ryuta Mikawa; Shumpei Niida; Osamu Takikawa; Yoshiro Saito
Journal:  Lipids Health Dis       Date:  2013-05-09       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.